Polio immunity to killed vaccine: an 18-year follow-up
- PMID: 2251870
- DOI: 10.1016/0264-410x(90)90244-g
Polio immunity to killed vaccine: an 18-year follow-up
Abstract
Two hundred and fifty children born in 1967 and vaccinated with killed polio vaccine in Sweden were followed for 18 years and tested for neutralizing antibodies against polio. All of them had demonstrable antibodies at the age of 18. Sixty-four children were tested in samples collected throughout the years. After a more marked fall of antibody titres during the first few years after vaccination, the decline levelled off to a mean decrease in titre of 0.05-0.10 log10 per year. In half of them, the routine vaccination comprising a fourth dose at 6 years of age was changed and this booster was postponed to the age of ten. The children given the booster dose at ten had significantly higher antibody levels at 18 years of age than those given it at six.
Comment in
-
Are booster doses of poliovirus vaccine necessary?Vaccine. 1990 Oct;8(5):419-20. doi: 10.1016/0264-410x(90)90239-i. Vaccine. 1990. PMID: 2174593
Similar articles
-
Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus.Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S548-51. doi: 10.1093/clinids/6.supplement_2.s548. Rev Infect Dis. 1984. PMID: 6740100
-
Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV.Vaccine. 2015 Jul 31;33(32):3988-96. doi: 10.1016/j.vaccine.2015.06.036. Epub 2015 Jun 15. Vaccine. 2015. PMID: 26087294
-
A study of the sero-immunity that has protected the Swedish population against poliomyelitis for 25 years.Scand J Infect Dis. 1987;19(6):595-601. doi: 10.3109/00365548709117192. Scand J Infect Dis. 1987. PMID: 2831621
-
Vaccinology of poliomyelitis.Vaccine. 1984 Mar;2(1):59-74. doi: 10.1016/s0264-410x(98)90035-4. Vaccine. 1984. PMID: 6099644 Review.
-
Control of influenza and poliomyelitis with killed virus vaccines.Science. 1977 Mar 4;195(4281):834-47. doi: 10.1126/science.320661. Science. 1977. PMID: 320661 Review.
Cited by
-
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial.Lancet Microbe. 2023 Nov;4(11):e923-e930. doi: 10.1016/S2666-5247(23)00215-X. Epub 2023 Sep 26. Lancet Microbe. 2023. PMID: 37774729 Free PMC article. Clinical Trial.
-
Bartonella infections are prevalent in rodents despite efficient immune responses.Parasit Vectors. 2023 Sep 4;16(1):315. doi: 10.1186/s13071-023-05918-7. Parasit Vectors. 2023. PMID: 37667323 Free PMC article.
-
Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses.PLoS Pathog. 2022 Feb 14;18(2):e1010327. doi: 10.1371/journal.ppat.1010327. eCollection 2022 Feb. PLoS Pathog. 2022. PMID: 35157732 Free PMC article.
-
Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.mBio. 2022 Feb 22;13(1):e0366021. doi: 10.1128/mbio.03660-21. Epub 2022 Jan 18. mBio. 2022. PMID: 35038922 Free PMC article.
-
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.Vaccine. 2020 May 6;38(21):3780-3789. doi: 10.1016/j.vaccine.2020.02.066. Epub 2020 Apr 6. Vaccine. 2020. PMID: 32273184 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
